Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 2137084
PUBLISHER: GlobalData | PRODUCT CODE: 2137084
Age Related Macular Degeneration - Global Clinical Trials Review, 2026
PUBLISHED:
PAGES: 1100 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
GlobalData's clinical trial report, "Age Related Macular Degeneration - Global Clinical Trials Review, 2026" provides an overview of Age Related Macular Degeneration Clinical trials scenario. This report provides top line data relating to the clinical trials on Age Related Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Product Code: GDHC7366CTIDB
Table of Contents
Table of Contents
List of Tables
List of Figures
- Report Guidance
- GlobalData Clinical Trials Report Coverage
- Clinical Trials by Region
- Clinical Trials and Average Enrollment by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Five Countries Contributing to Clinical Trials in Middle East and Africa
- Top Five Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by G7 Countries: Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials
- Clinical Trials by Phase in G7 Countries
- Clinical Trials in G7 Countries by Trial Status
- Clinical Trials by E7 Countries: Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials
- Clinical Trials by Phase in E7 Countries
- Clinical Trials in E7 Countries by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Clinical Trials by End Point Status
- Subjects Recruited Over a Period of Time
- Clinical Trials by Sponsor Type
- Prominent Sponsors
- Top Companies Participating in Age Related Macular Degeneration Therapeutics Clinical Trials
- Prominent Drugs
- Latest Clinical Trials News on Age Related Macular Degeneration
- Jul 17, 2026: Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results From Expanded Neovascular AMD Cohorts
- Jul 15, 2026: Voluntary and Business Update Announcement Approval of Clinical Trials for AMD Indication of Innovative Drug Complement Factor B Inhibitor CMS-D017
- Jul 14, 2026: Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity for Geographic Atrophy at ASRS 2026
- Jul 13, 2026: Ollin Biosciences Announces Upcoming Presentations of OLN324 Data in Diabetic Macular Edema and wAMD at the ASRS 44th Annual Scientific Meeting
- Jul 10, 2026: Nanoscope Therapeutics to Present at 2026 American Society of Retina Specialists Annual Scientific Meeting
- Jun 23, 2026: Kalaris Announces Upcoming Presentation of TH103 Phase 1a Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling
- Jun 11, 2026: Approval for Clinical Trial of the Group's Product TUL321 Capsules
- Jun 04, 2026: Innovative Drug Update | Kexing Biopharm Enrolls First Subject in China-Based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10
- Clinical Trial Profile Snapshots
Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About GlobalData
- Contact Us
- Source
Product Code: GDHC7366CTIDB
List of Table
List of Tables
- Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Region, 2026*
- Age Related Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2026*
- Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2026*
- Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2026*
- Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2026*
- Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2026*
- Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2026*
- Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2026*
- Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2026*
- Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Phase, 2026*
- Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase 2026*
- Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2021-2025
- Age Related Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2026*
List of Figure
List of Figures
- Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Region (%), 2026*
- Age Related Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2026*
- Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries (%), 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2026*
- Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2026*
- Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2026*
- Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2026*
- Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2026*
- Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2026*
- Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2026*
- Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Phase (%), 2026*
- Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase, 2026*
- Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
- Age Related Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2026*
- Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2026*
- GlobalData Methodology
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.